FDA seeks more safety data on Lilly’s weight loss pill The U.S. Food and Drug Administration has asked Eli Lilly to gather additional safety information for its new weight loss pill, including whether the medication could be linked to liver and heart risks. The request, described as an effort to…
Continue reading...
Continue reading...